AbbVie Files Form 10-K; Calls Annual Meeting of Stockholders

PR Newswire/Les Echos/ 
AbbVie Files Form 10-K; Calls Annual Meeting of Stockholders 
NORTH CHICAGO, Ill., March 18, 2013 -- AbbVie Inc. ("AbbVie") (NYSE / CHX /
Euronext Paris / SIX: ABBV) informs its stockholders that it has filed its
Annual Report on Form 10-K with the U.S. Securities and Exchange Commission
AbbVie also informs its stockholders that the Annual Meeting of Stockholders
will be held at the Beechwood Hotel, 363 Plantation Street, Worcester,
Massachusetts 01605, on Monday, May 6, 2013, at 9:00 a.m. for the following
* To elect three directors to hold office until the next Annual Meeting or 
until their successors are elected,
  * To ratify the appointment of Ernst & Young LLP as auditors of AbbVie for 
  * To vote on an advisory vote on the approval of executive compensation,
  * To determine, in an advisory vote, whether the stockholder advisory vote  
to approve executive compensation should occur every one, two or three  
  * To approve the AbbVie 2013 Incentive Stock Program, and
  * To transact such other business as may properly come before the meeting. 
The close of business on March 8, 2013, has been fixed as the record date for
determining the stockholders entitled to receive notice of and to vote at the
Annual Meeting. 
AbbVie makes available free of charge on its website, its Annual Report on 
Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, 
reports filed pursuant to Section 16 of the U.S. Securities Exchange Act of 
1934 and amendments to those reports filed with or furnished to the SEC as 
soon as reasonably practicable after AbbVie electronically files these 
documents with, or furnishes them to, the SEC. These documents are posted on 
AbbVie's website at 
The SEC maintains a website that contains reports, proxy statements and other
information regarding issuers that file electronically with the SEC. These
materials may be obtained electronically by accessing the SEC's home page at 
Copies of the above referenced information will also be made available, free 
of charge, upon written request to AbbVie Inc., Investors Relations, 1 North
Waukegan Road, North Chicago, Illinois 60064, U.S.A.

SOURCE AbbVie Inc. 
The content and accuracy of news releases published on this site and/or 
distributed by PR Newswire or its partners are the sole responsibility of the 
originating company or organisation. Whilst every effort is made to ensure the 
accuracy of our services, such releases are not actively monitored or reviewed 
by PR Newswire or its partners and under no circumstances shall PR Newswire or 
its partners be liable for any loss or damage resulting from the use of such 
information. All information should be checked prior to publication. 
-0- Mar/19/2013 07:56 GMT
Press spacebar to pause and continue. Press esc to stop.